Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)

Abstract MBL is a precursor condition to chronic lymphocytic leukemia (CLL), characterized by monoclonal B-cells in blood. Mosaic chromosomal alterations (mCAs) are a form of clonal hematopoiesis that include gains, losses, and copy-neutral loss-of-heterozygosity of large DNA segments. Both MBL and...

Full description

Saved in:
Bibliographic Details
Main Authors: Aswin Sekar, Rosalie Griffin, Sameer A. Parikh, Giulio Genovese, Dennis P. Robinson, Aaron D. Norman, Janet E. Olson, Kari G. Rabe, Mingma S. Hoel, Nicholas J. Boddicker, Paul J. Hampel, Neil E. Kay, James R. Cerhan, Esteban Braggio, Curtis A. Hanson, Celine M. Vachon, Tait D. Shanafelt, Benjamin L. Ebert, Susan L. Slager
Format: Article
Language:English
Published: Nature Publishing Group 2024-11-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-024-01175-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846172267795447808
author Aswin Sekar
Rosalie Griffin
Sameer A. Parikh
Giulio Genovese
Dennis P. Robinson
Aaron D. Norman
Janet E. Olson
Kari G. Rabe
Mingma S. Hoel
Nicholas J. Boddicker
Paul J. Hampel
Neil E. Kay
James R. Cerhan
Esteban Braggio
Curtis A. Hanson
Celine M. Vachon
Tait D. Shanafelt
Benjamin L. Ebert
Susan L. Slager
author_facet Aswin Sekar
Rosalie Griffin
Sameer A. Parikh
Giulio Genovese
Dennis P. Robinson
Aaron D. Norman
Janet E. Olson
Kari G. Rabe
Mingma S. Hoel
Nicholas J. Boddicker
Paul J. Hampel
Neil E. Kay
James R. Cerhan
Esteban Braggio
Curtis A. Hanson
Celine M. Vachon
Tait D. Shanafelt
Benjamin L. Ebert
Susan L. Slager
author_sort Aswin Sekar
collection DOAJ
description Abstract MBL is a precursor condition to chronic lymphocytic leukemia (CLL), characterized by monoclonal B-cells in blood. Mosaic chromosomal alterations (mCAs) are a form of clonal hematopoiesis that include gains, losses, and copy-neutral loss-of-heterozygosity of large DNA segments. Both MBL and mCAs have been found to increase the risk of CLL and lymphoid malignancies, and the aim of our study was to investigate how mCAs relate to MBL, which is currently unknown. We analyzed genetic, flow cytometric, and hematologic data from 4632 individuals from the Mayo Clinic Biobank and CLL Database. MBL was detected using flow cytometry and classified as high-count (HC) or low-count (LC) MBL based on clone size. mCAs were detected primarily from whole blood DNA using sensitive SNP-array-based analyses. mCAs commonly altered in CLL (deletion of 6q, 11q, 13q, 17p, and trisomy 12) were specific (>99%) to individuals with MBL and CLL. HC-MBL and LC-MBL individuals were 881-fold and 8-fold, respectively, more likely to harbor CLL-associated mCAs than those without MBL. The cell fraction bearing these mCAs typically exceeded the B-cell fraction, suggesting their origin prior to the B-cell lineage. Integrating genetic and blood count data enabled detecting HC-MBL with high specificity in a biobank sample. These results quantify the contribution of mCAs to MBL and could enable large studies of HC-MBL without the need for flow cytometric screening.
format Article
id doaj-art-c4ee9d74bb144a50aa27abf28e99a8eb
institution Kabale University
issn 2044-5385
language English
publishDate 2024-11-01
publisher Nature Publishing Group
record_format Article
series Blood Cancer Journal
spelling doaj-art-c4ee9d74bb144a50aa27abf28e99a8eb2024-11-10T12:08:41ZengNature Publishing GroupBlood Cancer Journal2044-53852024-11-011411810.1038/s41408-024-01175-8Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)Aswin Sekar0Rosalie Griffin1Sameer A. Parikh2Giulio Genovese3Dennis P. Robinson4Aaron D. Norman5Janet E. Olson6Kari G. Rabe7Mingma S. Hoel8Nicholas J. Boddicker9Paul J. Hampel10Neil E. Kay11James R. Cerhan12Esteban Braggio13Curtis A. Hanson14Celine M. Vachon15Tait D. Shanafelt16Benjamin L. Ebert17Susan L. Slager18Department of Medical Oncology, Dana-Farber Cancer InstituteDivision of Computational Biology, Mayo ClinicDivision of Hematology, Mayo ClinicDepartment of Genetics, Harvard Medical SchoolDivision of Clinical Trials and Biostatistics, Mayo ClinicDivision of Epidemiology, Mayo ClinicDivision of Epidemiology, Mayo ClinicDivision of Clinical Trials and Biostatistics, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Computational Biology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Epidemiology, Mayo ClinicDepartment of Hematology/Oncology, Mayo ClinicDepartment of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo ClinicDivision of Epidemiology, Mayo ClinicDepartment of Medicine, Division of Hematology, Stanford UniversityDepartment of Medical Oncology, Dana-Farber Cancer InstituteDivision of Computational Biology, Mayo ClinicAbstract MBL is a precursor condition to chronic lymphocytic leukemia (CLL), characterized by monoclonal B-cells in blood. Mosaic chromosomal alterations (mCAs) are a form of clonal hematopoiesis that include gains, losses, and copy-neutral loss-of-heterozygosity of large DNA segments. Both MBL and mCAs have been found to increase the risk of CLL and lymphoid malignancies, and the aim of our study was to investigate how mCAs relate to MBL, which is currently unknown. We analyzed genetic, flow cytometric, and hematologic data from 4632 individuals from the Mayo Clinic Biobank and CLL Database. MBL was detected using flow cytometry and classified as high-count (HC) or low-count (LC) MBL based on clone size. mCAs were detected primarily from whole blood DNA using sensitive SNP-array-based analyses. mCAs commonly altered in CLL (deletion of 6q, 11q, 13q, 17p, and trisomy 12) were specific (>99%) to individuals with MBL and CLL. HC-MBL and LC-MBL individuals were 881-fold and 8-fold, respectively, more likely to harbor CLL-associated mCAs than those without MBL. The cell fraction bearing these mCAs typically exceeded the B-cell fraction, suggesting their origin prior to the B-cell lineage. Integrating genetic and blood count data enabled detecting HC-MBL with high specificity in a biobank sample. These results quantify the contribution of mCAs to MBL and could enable large studies of HC-MBL without the need for flow cytometric screening.https://doi.org/10.1038/s41408-024-01175-8
spellingShingle Aswin Sekar
Rosalie Griffin
Sameer A. Parikh
Giulio Genovese
Dennis P. Robinson
Aaron D. Norman
Janet E. Olson
Kari G. Rabe
Mingma S. Hoel
Nicholas J. Boddicker
Paul J. Hampel
Neil E. Kay
James R. Cerhan
Esteban Braggio
Curtis A. Hanson
Celine M. Vachon
Tait D. Shanafelt
Benjamin L. Ebert
Susan L. Slager
Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)
Blood Cancer Journal
title Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)
title_full Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)
title_fullStr Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)
title_full_unstemmed Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)
title_short Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)
title_sort mosaic chromosomal alterations mcas in individuals with monoclonal b cell lymphocytosis mbl
url https://doi.org/10.1038/s41408-024-01175-8
work_keys_str_mv AT aswinsekar mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT rosaliegriffin mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT sameeraparikh mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT giuliogenovese mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT dennisprobinson mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT aarondnorman mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT janeteolson mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT karigrabe mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT mingmashoel mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT nicholasjboddicker mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT pauljhampel mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT neilekay mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT jamesrcerhan mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT estebanbraggio mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT curtisahanson mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT celinemvachon mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT taitdshanafelt mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT benjaminlebert mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl
AT susanlslager mosaicchromosomalalterationsmcasinindividualswithmonoclonalbcelllymphocytosismbl